Quigley Jill M.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Nov 5, 2025
- Accession no.
- 0001799780-25-000004
- Filed
- Nov 5, 2025
- Trade date
- Nov 4, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $441.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quigley Jill M.CIK 0001799780 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +24,520 | $9.24 | +$226,564.8 | 24,520 | Direct | |
| Nov 4, 2025 | Common Stock | SSaleDisposed | −24,520 | $18.00 | −$441,360 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −24,520 | $0.00 | $0 | 3,955 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.